Latigo Biotherapeutics, Inc. (LTGO) stock
LTGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026
$13.76+1.16 (+9.21%)
Close on Nov 17, 2026Market cap $912.28MP/E –Yield 0.00%
Latigo Biotherapeutics total assets
Total assets on the balance sheet at the end of each period.
Latigo Biotherapeutics's total assets was $408.46M at Sep 30, 2026. For fiscal 2025 it was $75.52M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.52M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $408.46M | – |
| Q2 FY2026 | Jun 30, 2026 | $64.76M | – |
| Q4 FY2025 | Dec 31, 2025 | $75.52M | – |
See a number that looks wrong?